MedPath

Sulfacetamide Sodium

Sulfacetamide SodiumOphthalmic Solution USP, 10%

Approved
Approval ID

f43da9e1-1ed7-48e6-b6f4-4794ba0644a1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 1, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sulfacetamide Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-525
Application NumberANDA089560
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sulfacetamide Sodium
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateDecember 7, 2005
FDA Product Classification

INGREDIENTS (6)

sulfacetamide sodiumActive
Quantity: 100 mg in 1 mL
Code: 4NRT660KJQ
Classification: ACTIB
sodium thiosulfateInactive
Quantity: 3.1 mg in 1 mL
Code: HX1032V43M
Classification: IACT
propylparabenInactive
Quantity: 0.1 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT
methylparabenInactive
Quantity: 0.5 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
METHYLCELLULOSE (100 CPS)Inactive
Quantity: 5 mg in 1 mL
Code: 4GFU244C4J
Classification: IACT
SODIUM PHOSPHATE, MONOBASICInactive
Quantity: 0.93 mg in 1 mL
Code: 3980JIH2SW
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sulfacetamide Sodium - FDA Drug Approval Details